FR2248027B2 - - Google Patents

Info

Publication number
FR2248027B2
FR2248027B2 FR7337178A FR7337178A FR2248027B2 FR 2248027 B2 FR2248027 B2 FR 2248027B2 FR 7337178 A FR7337178 A FR 7337178A FR 7337178 A FR7337178 A FR 7337178A FR 2248027 B2 FR2248027 B2 FR 2248027B2
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7337178A
Other versions
FR2248027A2 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SERDEX SAS
Original Assignee
SERDEX SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SERDEX SAS filed Critical SERDEX SAS
Priority to FR7337178A priority Critical patent/FR2248027B2/fr
Priority to US05/514,778 priority patent/US4011328A/en
Publication of FR2248027A2 publication Critical patent/FR2248027A2/fr
Application granted granted Critical
Publication of FR2248027B2 publication Critical patent/FR2248027B2/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7337178A 1973-10-18 1973-10-18 Expired FR2248027B2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR7337178A FR2248027B2 (fr) 1973-10-18 1973-10-18
US05/514,778 US4011328A (en) 1973-10-18 1974-10-15 Derivatives of pyridine-3-acetic acid, process for their preparation and applications thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7337178A FR2248027B2 (fr) 1973-10-18 1973-10-18

Publications (2)

Publication Number Publication Date
FR2248027A2 FR2248027A2 (fr) 1975-05-16
FR2248027B2 true FR2248027B2 (fr) 1977-09-09

Family

ID=9126596

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7337178A Expired FR2248027B2 (fr) 1973-10-18 1973-10-18

Country Status (2)

Country Link
US (1) US4011328A (fr)
FR (1) FR2248027B2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5596008A (en) * 1995-02-10 1997-01-21 G. D. Searle & Co. 3,4-Diaryl substituted pyridines for the treatment of inflammation
US5686470A (en) * 1995-02-10 1997-11-11 Weier; Richard M. 2, 3-substituted pyridines for the treatment of inflammation
US6512121B2 (en) 1998-09-14 2003-01-28 G.D. Searle & Co. Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
WO1996038418A1 (fr) 1995-06-02 1996-12-05 G.D. Searle & Co. Derives heterocyclo-substitues d'acide hydroxamique utilises comme inhibiteurs de la cyclo-oxygenase-2 et de la 5-lipoxygenase
US6515014B2 (en) 1995-06-02 2003-02-04 G. D. Searle & Co. Thiophene substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
US6677364B2 (en) 1998-04-20 2004-01-13 G.D. Searle & Co. Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors
US6174901B1 (en) * 1998-12-18 2001-01-16 Amgen Inc. Substituted pyridine and pyridazine compounds and methods of use
US20030105144A1 (en) 2001-04-17 2003-06-05 Ping Gao Stabilized oral pharmaceutical composition
CA2479744A1 (fr) * 2002-03-28 2003-10-09 Paul E. Finke 2,3-diphenyl-pyridines substituees
US7329401B2 (en) * 2002-04-15 2008-02-12 The Regents Of The University Of California Cyclooxygenase-2 selective agents useful as imaging probes and related methods
EP1628665A2 (fr) * 2003-04-16 2006-03-01 Amgen Inc. Derivés 3-phenyl-4-(pyrimidin-2-yl)-6-(piperidin-4-yl) et composés similaires comme inhibiteurs tnf-alpha et il-1 pour le traitemet d'inflammations
FR2856684B1 (fr) * 2003-06-26 2008-04-11 Sanofi Synthelabo Derives de diphenylpyridine, leur preparation et leur application en therapeutique
WO2008141013A1 (fr) * 2007-05-08 2008-11-20 Allergan, Inc. Inhibiteurs de récepteur s1p3 pour traiter la douleur

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1147068A (en) * 1966-12-02 1969-04-02 Ici Ltd Phenyl-pyridine derivatives
NL6816241A (fr) * 1967-12-01 1969-06-03

Also Published As

Publication number Publication date
US4011328A (en) 1977-03-08
FR2248027A2 (fr) 1975-05-16

Similar Documents

Publication Publication Date Title
AR201758A1 (fr)
AU476761B2 (fr)
AR201235Q (fr)
AR201231Q (fr)
AU474593B2 (fr)
AU474511B2 (fr)
AU474838B2 (fr)
AU471343B2 (fr)
AU465434B2 (fr)
FR2248027B2 (fr)
AU476714B2 (fr)
AR201229Q (fr)
AU472848B2 (fr)
AU476696B2 (fr)
AU466283B2 (fr)
AR199451A1 (fr)
AU480131B2 (fr)
AR197627A1 (fr)
AR196382A1 (fr)
AR193950A1 (fr)
AR201432A1 (fr)
AR195311A1 (fr)
AR195948A1 (fr)
AR200256A1 (fr)
AR200885A1 (fr)